TCG Crossover GP II, LLC 13D and 13G filings for Cidara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-03 4:34 pm Purchase | 2024-11-26 | 13G | Cidara Therapeutics, Inc. CDTX | TCG Crossover GP II, LLC | 1,005,901 9.200% | 1,005,901 (New Position) | Filing |